Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jul 25;13:954616. doi: 10.3389/fimmu.2022.954616

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Zhang, Yu, Li, Wang, Jiao, Liang and Niu

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Prognostic value of the gene signature to chemotherapy and immunotherapy. (A) Comparison of RS among patients with complete response and progressive disease after chemotherapy. (B) The KM survival curve of OS between high and low RS groups in patients after chemotherapy. (C) Distribution of TIDE value in TCGA cohort. (D) Comparison of the proportion of responders and non-responders in different RS groups of TCGA cohort. (E) The association between IPS and RS groups. (F) The KM survival curve of OS between high and low RS groups in the IMvigor210 cohort. (G) Comparison of outcomes after receiving immunotherapy in different RS groups in the IMgivor210 cohort. ****p<0.0001.